DE3789196D1 - Fibrinolytische zusammensetzung. - Google Patents

Fibrinolytische zusammensetzung.

Info

Publication number
DE3789196D1
DE3789196D1 DE87903587T DE3789196T DE3789196D1 DE 3789196 D1 DE3789196 D1 DE 3789196D1 DE 87903587 T DE87903587 T DE 87903587T DE 3789196 T DE3789196 T DE 3789196T DE 3789196 D1 DE3789196 D1 DE 3789196D1
Authority
DE
Germany
Prior art keywords
c2h4o
c3h6o
integer
fibrinolytic composition
represented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE87903587T
Other languages
English (en)
Other versions
DE3789196T2 (de
Inventor
Robert Hunter
Alexander Duncan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emory University
Original Assignee
Emory University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/045,459 external-priority patent/US4801452A/en
Application filed by Emory University filed Critical Emory University
Publication of DE3789196D1 publication Critical patent/DE3789196D1/de
Application granted granted Critical
Publication of DE3789196T2 publication Critical patent/DE3789196T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A61K38/166—Streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DE3789196T 1986-05-15 1987-05-08 Fibrinolytische zusammensetzung. Expired - Fee Related DE3789196T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US86358286A 1986-05-15 1986-05-15
US4388887A 1987-04-29 1987-04-29
US07/045,459 US4801452A (en) 1986-05-15 1987-05-07 Fibrinolytic composition
PCT/US1987/001067 WO1987006836A1 (en) 1986-05-15 1987-05-08 Fibrinolytic composition

Publications (2)

Publication Number Publication Date
DE3789196D1 true DE3789196D1 (de) 1994-04-07
DE3789196T2 DE3789196T2 (de) 1994-06-16

Family

ID=27366409

Family Applications (2)

Application Number Title Priority Date Filing Date
DE3789196T Expired - Fee Related DE3789196T2 (de) 1986-05-15 1987-05-08 Fibrinolytische zusammensetzung.
DE3751907T Expired - Fee Related DE3751907T2 (de) 1986-05-15 1987-05-08 Injizierbares Arzneimittel zum Schutz vor Gewebebeschädigung durch Ischemie

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE3751907T Expired - Fee Related DE3751907T2 (de) 1986-05-15 1987-05-08 Injizierbares Arzneimittel zum Schutz vor Gewebebeschädigung durch Ischemie

Country Status (11)

Country Link
EP (3) EP0498470B1 (de)
JP (9) JPH0610139B2 (de)
KR (1) KR880701107A (de)
AT (1) ATE142502T1 (de)
AU (1) AU599392B2 (de)
BR (1) BR8707308A (de)
DE (2) DE3789196T2 (de)
DK (1) DK10888A (de)
FI (1) FI94928C (de)
IL (1) IL82519A (de)
WO (1) WO1987006836A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8503097A (nl) * 1985-11-11 1987-06-01 Leuven Res & Dev Vzw Geneesmiddel met thrombolytische werking.
US5182106A (en) * 1986-05-15 1993-01-26 Emory University Method for treating hypothermia
US5648071A (en) * 1986-05-15 1997-07-15 Emory University Method of treating tumors
US5039520A (en) * 1986-05-15 1991-08-13 Emory University Plasma extender
JPH0610139B2 (ja) * 1986-05-15 1994-02-09 エモリ ユニバーシティ 繊維素溶解性合成物混合物及び血管内の血餅溶解用薬剤
US4879109A (en) * 1986-05-15 1989-11-07 Emory University Method for treating burns
US5811088A (en) * 1987-02-20 1998-09-22 Emory University Antiinfective compounds and methods of use
US5582862A (en) * 1988-04-04 1996-12-10 General Hospital Corporation Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin
JP2871775B2 (ja) * 1988-04-04 1999-03-17 ザ、ゼネラル、ホスピタル、コーポレーション 血餅溶解の促進のための組成物及び方法
US5372812A (en) * 1988-04-04 1994-12-13 The General Hospital Corporation Composition and method for acceleration of clot lysis
ES2085352T3 (es) * 1989-05-17 1996-06-01 Res Corp Technologies Inc Metodo y composicion para el tratamiento de la trombosis en un mamifero.
US7202225B1 (en) 1993-10-15 2007-04-10 Emanuele R Martin Therapeutic delivery compositions and methods of use thereof
US5696298A (en) * 1991-03-19 1997-12-09 Cytrx Corporation Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
ATE187154T1 (de) 1991-03-19 1999-12-15 Cytrx Corp Polyoxypropylen/polyoxyethylen copolymere mit verbesserter biologischer aktivität
USRE38558E1 (en) 1991-03-19 2004-07-20 Cytrx Corporation Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
US6933286B2 (en) 1991-03-19 2005-08-23 R. Martin Emanuele Therapeutic delivery compositions and methods of use thereof
US5470568A (en) * 1992-02-13 1995-11-28 Arch Development Corporation Methods and compositions of a polymer (poloxamer) for cell repair
US5605687A (en) * 1992-05-15 1997-02-25 Arch Development Corporation Methods and compositions of a polymer (poloxamer) for repair of electrical injury
GB2289069B (en) * 1994-03-31 1997-12-17 Toppan Moore Kk Microcapsule-containing oil-based coating liquid,ink,coated sheet,and method of prepring the same
WO1995033474A1 (fr) * 1994-06-03 1995-12-14 Tsumura & Co. Composition medicinale
KR100241202B1 (ko) * 1995-09-12 2000-02-01 니시무로 타이죠 전류미러회로
WO1998012334A2 (en) * 1996-09-20 1998-03-26 The General Hospital Corporation Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin
US6969515B2 (en) 1999-11-13 2005-11-29 Talecris Biotherapeutics, Inc. Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
US6964764B2 (en) 1999-11-13 2005-11-15 Talecris Biotherapeutics, Inc. Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
US7544500B2 (en) 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition
US6355243B1 (en) * 1999-11-13 2002-03-12 Bayer Corporation Method of thrombolysis by local delivery of active plasmin
WO2002017714A2 (en) * 2000-08-25 2002-03-07 Organ Recovery Systems, Inc. Methods of thrombolytic organ treatment and repair
DE10314083A1 (de) * 2003-03-28 2004-10-14 Mcs Micro Carrier Systems Gmbh Produkt zum Schutz von Blutgefäßen
EP1839675A1 (de) * 2004-09-28 2007-10-03 Japan Science and Technology Agency Neues verfahren zum schutz vor ischämischer kardiopathie
JP5529369B2 (ja) 2006-09-11 2014-06-25 東ソー株式会社 熔融石英ガラスおよびその製造方法
PT2403865E (pt) 2009-03-03 2015-11-18 Grifols Therapeutics Inc Métodos de preparação de plasminogénio
SG11201501558RA (en) * 2012-09-08 2015-04-29 Organ Technologies Inc Method for maintaining organ or tissue for transplantation use for long period
EP3166617B1 (de) * 2014-07-07 2024-01-10 LifeRaft Biosciences, Inc. Poloxamer zusammensetzung frei von lang zirkulierendem material, methoden zur herstellung und verwendungen
GB201511207D0 (en) * 2015-06-25 2015-08-12 Xvivo Perfusion Ab Isolated organ evaluation and treatment
US20190104718A1 (en) * 2017-10-09 2019-04-11 Efran Cano Entry barrier

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3641240A (en) * 1968-09-27 1972-02-08 Wyandotte Chemicals Corp Method for the treatment of an embolus or thrombus
US3980772A (en) * 1969-12-02 1976-09-14 Baxter Laboratories, Inc. Methods of dissolving blood clots and the like with streptokinase chemically bonded to a carbohydrate matrix
US3956259A (en) * 1973-01-30 1976-05-11 Baxter Laboratories, Inc. Fractionation of blood using block copolymer of ethylene oxide and polyoxypropylene polymer to recover fraction suitable for organ perfusate
US4186253A (en) * 1978-10-10 1980-01-29 The Green Cross Corporation Perfusate for preserving organ to be transplanted and preserving method
US4609546A (en) * 1982-06-24 1986-09-02 Japan Chemical Research Co., Ltd. Long-acting composition
JPS5959629A (ja) * 1982-09-27 1984-04-05 Nippon Chem Res Kk 効力持続性組成物
JPS61176532A (ja) * 1985-01-30 1986-08-08 Green Cross Corp:The プラスミノ−ゲンアクチベ−タ−前駆体の安定化方法
JPH0610139B2 (ja) * 1986-05-15 1994-02-09 エモリ ユニバーシティ 繊維素溶解性合成物混合物及び血管内の血餅溶解用薬剤

Also Published As

Publication number Publication date
JPH0616562A (ja) 1994-01-25
AU7484087A (en) 1987-12-01
JPH0653685B2 (ja) 1994-07-20
EP0266419B1 (de) 1994-03-02
DK10888D0 (da) 1988-01-11
DE3751907D1 (de) 1996-10-17
EP0498470B1 (de) 1996-09-11
EP0451880A3 (en) 1991-12-27
JPH0624993A (ja) 1994-02-01
JPH0640924A (ja) 1994-02-15
JPH0735336B2 (ja) 1995-04-19
IL82519A (en) 1992-05-25
EP0498470A2 (de) 1992-08-12
EP0266419A1 (de) 1988-05-11
BR8707308A (pt) 1988-09-13
EP0498470A3 (en) 1993-03-03
JPH0616565A (ja) 1994-01-25
KR880701107A (ko) 1988-07-25
DK10888A (da) 1988-03-11
EP0266419A4 (de) 1989-03-15
JPH06100454A (ja) 1994-04-12
JPH0616567A (ja) 1994-01-25
ATE142502T1 (de) 1996-09-15
FI880163A (fi) 1988-01-14
FI94928C (fi) 1995-11-27
JPH0735337B2 (ja) 1995-04-19
EP0451880A2 (de) 1991-10-16
WO1987006836A1 (en) 1987-11-19
JPH0610139B2 (ja) 1994-02-09
FI880163A0 (fi) 1988-01-14
JPH0757730B2 (ja) 1995-06-21
JPH0648951A (ja) 1994-02-22
AU599392B2 (en) 1990-07-19
DE3789196T2 (de) 1994-06-16
FI94928B (fi) 1995-08-15
DE3751907T2 (de) 1997-04-03
JPH0616571A (ja) 1994-01-25
JPH0735338B2 (ja) 1995-04-19
JPH01500592A (ja) 1989-03-01

Similar Documents

Publication Publication Date Title
DE3789196T2 (de) Fibrinolytische zusammensetzung.
DE69725862D1 (de) Auf polymeren mit hohem molekulargewicht basierende medikamentvorstufen
ZA9010184B (en) Anti-viral compositions containing linked polyamines
DE69219221T2 (de) Vanadium Komplexe, ihre Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten
HUT67285A (en) Cyclic ureas and analogues and pharmaceutical compositions
FR2601259B1 (fr) Nouvelles compositions tensio-actives a base d'esters phosphoriques leur procede de preparation et leur application a la formulation de matieres actives.
JPS5663923A (en) Suppository base composition
MY101784A (en) Novel pharmacological compounds
JPS5429400A (en) Polymer comprising polyalkylpiperidine and its use as stabilizers
ATE67932T1 (de) Pharmazeutische zusammensetzungen fuer suppositorien.
GB1502873A (en) Pharmaceutical compositions with ulcer healing activity
EP0565146A3 (de) Verwendung eines Thioesters zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von Ischämie und von Reperfusion-Syndromen
FR2409996A1 (fr) 15-epi-prostacycline et analogues, utiles notamment comme agents antithrombotiques et thrombolytiques et leur procede de preparation
SE8802444D0 (sv) Brenslekomposition
GB1067935A (en) Improvements in or relating to nonapeptide derivatives
GB1424432A (en) Pharmaceutical compositions
FI911219A0 (fi) Ny pentapeptid och foerfarande foer framstaellning av densamma.
MX9101996A (es) Anestesico local
JPS6429452A (en) Epoxy resin composition for sealing semiconductor
FR2145568B1 (de)
KR920006354A (ko) 피라졸로퀴놀린 유도체
GB976217A (en) Improvements in or relating to novel substituted phenothiazines
KR900005972A (ko) 뉴모시티스 카리니 폐염 및 그밖의 질환의 치료방법과 예방법 및 그에 사용되는 화합물 및 제제

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee